People · Operator
Named in public records as an officer, director or promoter · active 2010–2017 · Hospitals and Physicians, AI / ML, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Rennova Health, Inc. | — | Hospitals and Physicians | Series B | $120.0M | $19.1M | 2017 |
| LungLife AI, Inc. | — | AI / ML | Series B | $68.4M | $2.9M | 2017 |
| Trovagene, Inc. | — | Biotechnology | Series A | $45.3M | $488.0M | 2017 |
| Biological Dynamics Inc | — | Biotechnology | Series B | $44.8M | $476.3M | 2015 |
| Bioscale Inc | — | Biotechnology | Series B | $44.7M | $747.7M | 2010 |
Paul Billings at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Paul Billings on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Miller | 1 | 27 |
| David Anderson | 1 | 21 |
| Somu Subramaniam | 1 | 17 |
| Isaac Cheng | 1 | 9 |
| William F. Doyle | 1 | 8 |
| Michael Pfau | 1 | 7 |
| Michael E. Pfau | 1 | 6 |
| Michael Russell | 1 | 6 |
| Alan Heeger | 1 | 5 |
| Paul Anderson | 1 | 5 |
| John Brancaccio | 1 | 5 |
| Antonius Schuh | 1 | 5 |
| Amit Munshi | 1 | 5 |
| Edward Crawley | 1 | 4 |
| William Doyle | 1 | 4 |
| Paul Maier | 1 | 4 |
| Rodney Markin | 1 | 4 |
| Michael Pollack | 1 | 3 |
| Gary Jacob | 1 | 3 |
| Bard Geesaman | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.